Meadow Creek Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Meadow Creek Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$239K	Buy	18,424 +560	+3%	+$6.76K	﹤0.01%	973
2019 Q2	$222K	Hold	17,864	–	–	﹤0.01%	1010
2019 Q1	$260K	Buy	17,864 +84	+0.5%	+$1.07K	0.01%	930
2018 Q4	$196K	Buy	17,780 +5,432	+44%	+$75.6K	﹤0.01%	967
2018 Q3	$325K	Buy	12,348 +1,736	+16%	+$46.9K	0.01%	901
2018 Q2	$217K	Hold	10,612	–	–	﹤0.01%	971
2018 Q1	$193K	Buy	10,612 +56	+0.5%	+$934	﹤0.01%	997
2017 Q4	$147K	Buy	10,556 +728	+7%	+$9.84K	﹤0.01%	1103
2017 Q3	$182K	Buy	9,828 +2,996	+44%	+$50.1K	﹤0.01%	959
2017 Q2	$116K	Buy	6,832 +3,528	+107%	+$53.7K	﹤0.01%	1054
2017 Q1	$44K	Sell	3,304 -616	-16%	-$9.65K	﹤0.01%	1184
2016 Q4	$59K	Buy	+3,920	New	+$51.8K	﹤0.01%	1079

Other funds holding MNTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Meadow Creek Investment Management's MNTA Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 3.1% in Q3 2019, buying an estimated $6.76K and bringing the position to 18,424 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Meadow Creek Investment Management first reported a position in MNTA in Q4 2016 and has held it in 12 quarters since. The position peaked at $325K in Q3 2018. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

Meadow Creek Investment Management held 18,424 shares of Momenta Pharmaceuticals, Inc. worth $239K as of Q3 2019.
Meadow Creek Investment Management bought 560 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $6.76K.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #973 holding.
Meadow Creek Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $325K in Q3 2018.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.